C
600062
vs
JNJ
C
600062
JNJ
Over the past 12 months, China Resources Double-Crane Pharmaceutical Co Ltd has underperformed JNJ, delivering a return of -1% compared to the JNJ's +46% growth.
This Feature is Available on
Paid Plans
Paid Plans
This Feature is Available on Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
14-day money-back guarantee
Smart Verdict
AI-Powered
Not Sure Which Stock Wins?
Let AI Decide.
Let AI Decide.
600062
JNJ
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Summarizing...
We need a little more time to summarize the results
Valuation Comparison
C
Intrinsic Value
27.78
CNY
Undervaluation 35%
JNJ
Intrinsic Value
172.09
USD
Overvaluation 25%
| Company | Last Price | Intrinsic Value | DCF Value | Multiples-Based Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
C
|
China Resources Double-Crane Pharmaceutical Co Ltd
SSE:600062
|
18.18
CNY
|
|||||
|
Johnson & Johnson
NYSE:JNJ
|
230.69
USD
|
|||||
No Stocks Selected
Compare the stock's valuation with its competitors.
Valuation Scenario:
Growth Comparison
Growth Over Time
600062, JNJ
600062, JNJ
Revenue
www.alphaspread.com
No Stocks Selected
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
C
|
China Resources Double-Crane Pharmaceutical Co Ltd
Revenue
|
|||||||||||
|
|
Johnson & Johnson
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
No Stocks Selected
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
600062, JNJ
600062, JNJ
Free Cash Flow
www.alphaspread.com
No Stocks Selected
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
C
|
China Resources Double-Crane Pharmaceutical Co Ltd
SSE:600062
|
|||||||||
|
|
Johnson & Johnson
NYSE:JNJ
|
|||||||||
No Stocks Selected
Compare company's free cash flow with its competitors.
Gross Margin
China Resources Double-Crane Pharmaceutical Co Ltd
57.8%
JNJ
67.9%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
China Resources Double-Crane Pharmaceutical Co Ltd | ||||
|
|
Johnson & Johnson | ||||
Operating Margin
China Resources Double-Crane Pharmaceutical Co Ltd
16%
JNJ
27.9%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
China Resources Double-Crane Pharmaceutical Co Ltd | ||||
|
|
Johnson & Johnson | ||||
Net Margin
China Resources Double-Crane Pharmaceutical Co Ltd
15%
JNJ
21.8%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
China Resources Double-Crane Pharmaceutical Co Ltd | ||||
|
|
Johnson & Johnson | ||||
FCF Margin
China Resources Double-Crane Pharmaceutical Co Ltd
7.9%
JNJ
20.4%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
China Resources Double-Crane Pharmaceutical Co Ltd | ||||
|
|
Johnson & Johnson | ||||
ROE
China Resources Double-Crane Pharmaceutical Co Ltd
14.9%
JNJ
27.5%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
China Resources Double-Crane Pharmaceutical Co Ltd | ||||
|
|
Johnson & Johnson | ||||
ROA
China Resources Double-Crane Pharmaceutical Co Ltd
9.8%
JNJ
11.1%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
China Resources Double-Crane Pharmaceutical Co Ltd | ||||
|
|
Johnson & Johnson | ||||
ROIC
China Resources Double-Crane Pharmaceutical Co Ltd
11.5%
JNJ
14.5%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
China Resources Double-Crane Pharmaceutical Co Ltd | ||||
|
|
Johnson & Johnson | ||||
ROCE
China Resources Double-Crane Pharmaceutical Co Ltd
13.2%
JNJ
19.5%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
China Resources Double-Crane Pharmaceutical Co Ltd | ||||
|
|
Johnson & Johnson | ||||
Solvency Comparison
C
China Resources Double-Crane Pha...
Equity Waterfall
Assets
Liabilities
Equity
No Stocks Selected
Compare company's equity waterfall with its competitors.
Balance Sheet Comparison
Stocks Performance
Stocks Performance
600062, JNJ
600062, JNJ
Performance By Year
600062, JNJ
600062, JNJ
Loading
No Stocks Selected
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Compare 600062 to other stocks
LLY
Eli Lilly and Co
More expensive
vs China Resources Double-Crane P...
ROG
Roche Holding AG
More expensive
vs China Resources Double-Crane P...
AZN
AstraZeneca PLC
More expensive
vs China Resources Double-Crane P...
MRK
Merck & Co Inc
More expensive
vs China Resources Double-Crane P...
Select Stock to Compare
| US |
|
Eli Lilly and Co
NYSE:LLY
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Loading...
Unlock Full Access to Alpha Spread
Create Free Account
